The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reasons for oncologist and urologist treatment choice in metastatic castration-sensitive prostate cancer (mCSPC): A physician survey linked to patient chart reviews in the United States.
 
Stephen J. Freedland
Employment - Genomic Health (I)
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Dendreon; Exact Sciences; Ferring; Janssen Biotech; Merck; Myovant Sciences; Pfizer; Sanofi
Speakers' Bureau - AstraZeneca; Sanofi
Research Funding - Bayer (Inst); Diasorin; GenomeDx (Inst); Janssen Biotech (Inst); MDxHealth (Inst); Merck; Myriad Genetics (Inst); OPKO Diagnostics (Inst); Progenika (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Zachary William Abraham Klaassen
Honoraria - Bayer; Pfizer/Astellas
Consulting or Advisory Role - Sesen Bio
 
Neeraj Agarwal
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Foundation Medicine; Foundation Medicine; Genentech; Gilead Sciences; Janssen Oncology; Lilly; Lilly; Lilly; Medivation/Astellas; MEI Pharma; Merck; Nektar; Novartis; Pfizer; Pfizer; Pharmacyclics; Seagen
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Takeda (Inst)
 
Rickard Sandin
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Andrea Leith
Research Funding - Astellas Pharma (Inst); Pfizer (Inst)
Other Relationship - Adelphi
 
Amanda Ribbands
Employment - Adelphi
Consulting or Advisory Role - Adelphi (Inst)
Research Funding - Adelphi (Inst)
 
Emily Clayton
Employment - Adelphi
Consulting or Advisory Role - Adelphi (Inst)
Research Funding - Adelphi (Inst)
 
Jake Butcher
Research Funding - Astellas Amgen BioPharama (Inst); Pfizer (Inst)
Other Relationship - Biomedical Advanced Research and Development Authority (BARDA) (Inst)
 
Liane Gillespie-Akar
No Relationships to Disclose
 
Dave Russell
Employment - Pfizer
Leadership - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Agnes Hong
Employment - Astellas Pharma
Stock and Other Ownership Interests - Abbvie; Merck; Veru
 
Krishnan Ramaswamy
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Research Funding - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Daniel J. George
Leadership - Capio BioSciences
Honoraria - Acceleron Pharma; American Association for Cancer Research; Axess Oncology; Bayer; EMD Serono; Exelixis; Janssen Oncology; Millennium Medical Publishing; OncLive; Pfizer; Sanofi; UroToday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Constellation Pharmaceuticals; Exelixis; Genentech; Innocrin Pharma; Janssen; Merck Sharp & Dohme; Michael J. Hennessy Associates; Myovant Sciences; Pfizer; Physicans' Education Resource; Propella Therapeutics; RevHealth; Sanofi; Xcures
Speakers' Bureau - Bayer; Exelixis; Sanofi
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Dendreon (Inst); Exelixis (Inst); Innocrin Pharma (Inst); Janssen Oncology (Inst); Novartis (Inst); Pfizer (Inst); Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - Bayer; Exelixis; Janssen Oncology; Merck; Pfizer; Sanofi; UroToday